We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

260 hedge funds and large institutions have $6.22B invested in Alnylam Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 98 increasing their positions, 75 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 75

18% more capital invested

Capital invested by funds: $5.26B → $6.22B (+$960M)

13% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 39

1% more funds holding

Funds holding: 257 → 260 (+3)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

17% less call options, than puts

Call options by funds: $21M | Put options by funds: $25.4M

Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
6.82%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.18%
New
44
Increased
98
Reduced
75
Closed
39
Calls
$21M
Puts
$25.4M
Net Calls
-$4.4M
Net Calls Change
-$20.5M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$187M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$38.6M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.9M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$14.7M
5
SPC
Slate Path Capital
New York
+$12.1M

Top Sellers

1
AAMU
Amundi Asset Management US
Massachusetts
-$50.8M
2
First Trust Advisors
First Trust Advisors
Illinois
-$31.4M
3
UIM
USS Investment Management
United Kingdom
-$22.2M
4
CCM
Camber Capital Management
Massachusetts
-$20.1M
5
GTP
Global Thematic Partners
New York
-$18.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACI
126
AMP Capital Investors
Australia
$1.86M -$867K -9,353 -32%
SEI Investments
127
SEI Investments
Pennsylvania
$1.84M +$1.51M +16,273 +494%
Susquehanna International Group
128
Susquehanna International Group
Pennsylvania
$1.78M -$12.8M -138,272 -88%
IRF
129
IBM Retirement Fund
New York
$1.7M +$202K +2,174 +14%
Public Employees Retirement Association of Colorado
130
Public Employees Retirement Association of Colorado
Colorado
$1.68M +$1.76K +19 +0.1%
CCMH
131
Cornerstone Capital Management Holdings
New York
$1.54M -$610K -6,575 -29%
Ameriprise
132
Ameriprise
Minnesota
$1.54M -$166K -1,790 -10%
BNP Paribas Financial Markets
133
BNP Paribas Financial Markets
France
$1.47M +$449K +4,847 +45%
KFS
134
Kurt F. Somerville
$1.43M +$213K +2,293 +18%
FAM
135
Fortaleza Asset Management
Illinois
$1.39M +$127K +1,365 +10%
Principal Financial Group
136
Principal Financial Group
Iowa
$1.27M +$1.95K +21 +0.2%
URS
137
Utah Retirement Systems
Utah
$1.25M – – –
Los Angeles Capital Management
138
Los Angeles Capital Management
California
$1.25M -$186K -2,005 -13%
JG
139
Jefferies Group
New York
$1.24M +$85.1K +918 +7%
Barclays
140
Barclays
United Kingdom
$1.22M -$2.43M -26,166 -67%
HTHT
141
Hemenway Trust Hemenway Trust
New Hampshire
$1.18M – – –
PC
142
Paulson & Co
New York
$1.16M +$1.14M +12,300 New
Comerica Bank
143
Comerica Bank
Texas
$1.15M -$21.6K -233 -2%
PP
144
Paloma Partners
Connecticut
$1.12M +$775K +8,360 +236%
HSBC Holdings
145
HSBC Holdings
United Kingdom
$1.08M -$646K -6,963 -38%
BBA
146
Baker Bros. Advisors
New York
$1.07M – – –
Credit Agricole
147
Credit Agricole
France
$1.03M -$149K -1,604 -13%
HI
148
HBK Investments
Texas
$998K -$797K -8,599 -45%
Janus Henderson Group
149
Janus Henderson Group
United Kingdom
$955K – – –
Nomura Holdings
150
Nomura Holdings
Japan
$951K +$9.27K +100 +1%
4 5
6
7 8

ALNY Hedge Fund Activity: Q4 2015 in Review

260 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q4 2015, worth a combined $6.22B — up 18% from $5.26B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ALNY positions and 39 closed out — a net gain of 5 holders — while 98 added to existing stakes and 75 trimmed.

The largest buyer was Baillie Gifford & Co, adding an estimated $187M. The largest seller was Amundi Asset Management US, exiting entirely with an estimated $50.8M sold.

  • 260 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q4 2015, up from 257 in Q3 2015.
  • Funds reported $6.22B of Alnylam Pharmaceuticals stock for Q4 2015, up 18% quarter-over-quarter.
  • 44 funds opened new Alnylam Pharmaceuticals positions in Q4 2015 and 39 closed out, a net change of +5 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q4 2015 was Baillie Gifford & Co, an estimated $187M added.
  • The largest Alnylam Pharmaceuticals seller in Q4 2015 was Amundi Asset Management US, an estimated $50.8M sold.

Based on aggregated 13F filings for Q4 2015.